Iannone Robert
- SEC CIK
- 0001737329
In the past year, 2 open-market sale filings worth $20.4M and no purchases.
Current role at each company
- JAZZ Jazz Pharmaceuticals plcEVP, Global Head of R&D & CMOas of Aug 31, 2026
- PLRX Pliant Therapeutics, Inc.Directoras of Jul 13, 2026
- AUTL Autolus Therapeutics plcDirectoras of Jul 1, 2026
- ITOS iTeos Therapeutics, Inc.Directoras of Jun 13, 2024
- JNCE Jounce Therapeutics, Inc.Directoras of May 4, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $20.4M
- 2 filings
- Net
- −$20.4M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Iannone Robert as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
JAZZ Jazz Pharmaceuticals plc
EVP, Global Head of R&D & CMO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 (view filing)6:45 PM ET | Aug 27 | 4 days | Iannone RobertEVP, Global Head of R&D & CMO | SSale | −76.9K | $249.70 | −$19.2M | −53.9%65.7K after | 6 lots10b5-1 |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Iannone RobertEVP, Global Head of R&D & CMO | SSale | −7.16K | $168.26 | −$1.20M | −9.0%72.6K after | 10b5-1 |
| Mar 12, 2025 (view filing) | Mar 10 | 2 days | Iannone RobertEVP, Global Head of R&D & CMO | SSale | −2.40K | $138.41 | −$332.6K | −2.9%79.6K after | |
| Mar 7, 2025 (view filing) | Mar 7 | Same day | Iannone RobertEVP, Global Head of R&D & CMO | SSale | −7.08K | $138.60 | −$981.3K | −7.9%82.0K after | 2 lots10b5-1 |
| Dec 13, 2022 (view filing) | Dec 9 | 4 days | Iannone RobertEVP, Global Head of R&D | SSale | −1.84K | $151.54 | −$279.4K | −4.8%36.3K after |